{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:16:44Z","timestamp":1793261804348,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bcp.2020.114314","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T19:54:11Z","timestamp":1604346851000},"page":"114314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Pharmacokinetics of CamSA, a potential prophylactic compound against Clostridioides difficile infections"],"prefix":"10.1016","volume":"183","author":[{"given":"Christopher","family":"Yip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9413-7109","authenticated-orcid":false,"given":"Naomi C.","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Howerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amei","family":"Amei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Abel-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2020.114314_b0005","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.tim.2014.04.003","article-title":"Clostridium difficile spore biology: sporulation, germination, and spore structural proteins","volume":"22","author":"Paredes-Sabja","year":"2014","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.bcp.2020.114314_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2018.00029","article-title":"Clostridioides difficile biology: sporulation, germination, and corresponding therapies for C. difficile infection","volume":"8","author":"Zhu","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bcp.2020.114314_b0015","unstructured":"C. Yip, J.R. Phan, E. Abel-Santos, Treatment of Clostridium difficile Infections, in: RSC Drug Discovery Series, vol. January (2017)."},{"key":"10.1016\/j.bcp.2020.114314_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mSphereDirect.00698-18","article-title":"The gut microbiota is associated with clearance of clostridium difficile infection independent of adaptive immunity","volume":"4","author":"Leslie","year":"2019","journal-title":"mSphere"},{"key":"10.1016\/j.bcp.2020.114314_b0025","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-1786-6","article-title":"Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study","volume":"16","author":"Zhang","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.bcp.2020.114314_b0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/cid\/cis335","article-title":"Burden of clostridium difficile on the healthcare system","volume":"55","author":"Dubberke","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bcp.2020.114314_b0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.medmal.2017.10.010","article-title":"Economic burden and cost-effective management of Clostridium difficile infections","volume":"48","author":"Heimann","year":"2018","journal-title":"Med. Mal. Infect."},{"key":"10.1016\/j.bcp.2020.114314_b0040","first-page":"1","article-title":"Clostridium difficile infection","volume":"7","author":"Klaas Smits","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.bcp.2020.114314_b0045","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/mmi.14091","article-title":"Peptidoglycan degradation machinery in Clostridium difficile forespore engulfment","volume":"110","author":"Dembek","year":"2018","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bcp.2020.114314_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2016.01698","article-title":"Chemical and stress resistances of clostridium difficile spores and vegetative cells","volume":"7","author":"Edwards","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bcp.2020.114314_b0055","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1021\/acs.jmedchem.8b00632","article-title":"The design, synthesis, and characterizations of spore germination inhibitors effective against an epidemic strain of clostridium difficile","volume":"61","author":"Yip","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2020.114314_b0060","series-title":"Molecular Medical Microbiology","article-title":"Endospores, sporulation and germination","author":"Abel-Santos","year":"2014"},{"key":"10.1016\/j.bcp.2020.114314_b0065","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1128\/JB.01765-07","article-title":"Bile salts and glycine as cogerminants for Clostridium difficile spores","volume":"190","author":"Sorg","year":"2008","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.bcp.2020.114314_b0070","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/JB.00488-10","article-title":"Kinetic evidence for the presence of putative germination receptors in Clostridium difficile spores","volume":"192","author":"Ramirez","year":"2010","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.bcp.2020.114314_b0075","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(97)08062-8","article-title":"Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea","volume":"351","author":"Shim","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2020.114314_b0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3727\/105221618X15156018385515","article-title":"Bile acid metabolism in liver pathobiology","volume":"18","author":"Chiang","year":"2018","journal-title":"Gene Expr."},{"key":"10.1016\/j.bcp.2020.114314_b0085","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","article-title":"Bile acids: regulation of synthesis","volume":"50","author":"Chiang","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bcp.2020.114314_b0090","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1021\/mp050101+","article-title":"Efflux mechanism of taurocholate across the rat intestinal basolateral membrane","volume":"3","author":"Sakamoto","year":"2006","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bcp.2020.114314_b0095","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00018-008-7568-6","article-title":"Bile acids: Chemistry, pathochemistry, biology, pathobiology, and therapeutics","volume":"65","author":"Hofmann","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcp.2020.114314_b0100","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1194\/jlr.R054114","article-title":"Intestinal transport and metabolism of bile acids","volume":"56","author":"Dawson","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bcp.2020.114314_b0105","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","article-title":"Bile salt biotransformations by human intestinal bacteria","volume":"47","author":"Ridlon","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bcp.2020.114314_b0110","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.femsre.2004.09.003","article-title":"The interaction between bacteria and bile","volume":"29","author":"Begley","year":"2005","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.bcp.2020.114314_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12688\/f1000research.12449.1","article-title":"Recent advances in understanding bile acid homeostasis","volume":"6","author":"Chiang","year":"2017","journal-title":"F1000Research"},{"key":"10.1016\/j.bcp.2020.114314_b0120","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.anaerobe.2016.05.003","article-title":"Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract","volume":"41","author":"Winston","year":"2016","journal-title":"Anaerobe"},{"key":"10.1016\/j.bcp.2020.114314_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1005157","article-title":"A gut Odyssey: the impact of the microbiota on clostridium difficile spore formation and germination","volume":"11","author":"Shen","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bcp.2020.114314_b0130","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1001\/archinte.159.22.2647","article-title":"The continuing importance of bile acids in liver and intestinal disease","volume":"159","author":"Hofmann","year":"1999","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bcp.2020.114314_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072620","article-title":"Fate of ingested clostridium difficile spores in mice","volume":"8","author":"Howerton","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2020.114314_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008740","article-title":"Metabolism of bile salts in mice influences spore germination in clostridium difficile","volume":"5","author":"Giel","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2020.114314_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032381","article-title":"Spores of clostridium difficile clinical isolates display a diverse germination response to bile salts","volume":"7","author":"Heeg","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2020.114314_b0150","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1128\/JB.00980-10","article-title":"Mapping interactions between germinants and clostridium difficile spores","volume":"193","author":"Howerton","year":"2011","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.bcp.2020.114314_b0155","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1128\/JB.01260-08","article-title":"Chenodeoxycholate is an inhibitor of Clostridium difficile spore germination","volume":"191","author":"Sorg","year":"2009","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.bcp.2020.114314_b0160","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/infdis\/jit068","article-title":"A new strategy for the prevention of Clostridium difficile infection","volume":"207","author":"Howerton","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bcp.2020.114314_b0165","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1021\/acs.jmedchem.7b00295","article-title":"Synthesis and biological evaluation of bile acid analogues inhibitory to clostridium difficile spore germination","volume":"60","author":"Stoltz","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2020.114314_b0170","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1128\/JB.00610-10","article-title":"Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid","volume":"192","author":"Sorg","year":"2010","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.bcp.2020.114314_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02251-17","article-title":"Effect of the synthetic bile salt analog CamSA on the hamster model of clostridium difficile infection","volume":"62","author":"Howerton","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2020.114314_b0180","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1128\/IAI.01336-10","article-title":"Mouse relapse model of Clostridium difficile infection","volume":"79","author":"Sun","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bcp.2020.114314_b0185","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1053\/j.gastro.2008.09.002","article-title":"A Mouse Model of Clostridium difficile-Associated Disease","volume":"135","author":"Chen","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2020.114314_b0190","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4161\/gmic.19142","article-title":"Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains","volume":"2","author":"Theriot","year":"2011","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bcp.2020.114314_b0195","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1039\/C2DT31833D","article-title":"Understanding the mechanism of cytochrome P450 3A4: recent advances and remaining problems","volume":"42","author":"Sevrioukova","year":"2013","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.bcp.2020.114314_b0200","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0022-2275(20)39519-5","article-title":"Extraction of bile acids from rat feces containing cholestyramine","volume":"12","author":"Manes","year":"1971","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bcp.2020.114314_b0205","first-page":"145","article-title":"Pharmacokinetics and pharmacodynamics of biotech drugs","volume":"10","author":"Meibohm","year":"2005","journal-title":"Pharm. Biotechnol."},{"key":"10.1016\/j.bcp.2020.114314_b0210","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00232-014-9715-3","article-title":"The mechanism of enterohepatic circulation in the formation of gallstone disease","volume":"247","author":"Cai","year":"2014","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.bcp.2020.114314_b0215","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/08998280.2000.11927719","article-title":"Drug interactions due to cytochrome P450","volume":"13","author":"Ogu","year":"2000","journal-title":"Baylor Univ. Med. Cent. Proc."},{"key":"10.1016\/j.bcp.2020.114314_b0220","first-page":"1","article-title":"The role of CYP3A4 in the biotransformation of bile acids and therapeutic implication for cholestasis","volume":"2","author":"Chen","year":"2014","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.bcp.2020.114314_b0225","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/jat.1720","article-title":"Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug-drug interactions","volume":"33","author":"Lee","year":"2013","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.bcp.2020.114314_b0230","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbalip.2004.11.003","article-title":"Novel pathways of bile acid metabolism involving CYP3A4","volume":"1687","author":"Bodin","year":"2005","journal-title":"Biochim. Biophys. Acta - Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.bcp.2020.114314_b0235","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1440-1746.1996.tb00095.x","article-title":"Bile acids produce a generalized reduction of the catalytic activity of cytochromes P450 and ether hepatic microsomal enzymes in vitro: relevance to drug metabolism in experimental cholestasis","volume":"11","author":"Chen","year":"1996","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2020.114314_b0240","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2165\/00003088-200241100-00005","article-title":"Enterohepatic circulation: physiological, pharmacokinetic and clinical implications","volume":"41","author":"Roberts","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bcp.2020.114314_b0245","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00500971","article-title":"Effect of enterohepatic circulation on the pharmacokinetics of spironolactone in man","volume":"300","author":"Abshagen","year":"1977","journal-title":"Naunyn. Schmiedebergs. Arch. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114314_b0250","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/019262339502300202","article-title":"An introduction to drug disposition: the basic principles of absorption, distribution, metabolism, and excretion","volume":"23","author":"Caldwell","year":"1995","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.bcp.2020.114314_b0255","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0300-483X(88)90110-2","article-title":"Evidence for an enterohepatic circulation of ochratoxin A in mice","volume":"48","author":"Roth","year":"1988","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2020.114314_b0260","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/03602532.2016.1157600","article-title":"Role of enterohepatic recirculation in drug disposition: cooperation and complications","volume":"48","author":"Malik","year":"2016","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.bcp.2020.114314_b0265","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2165\/11319320-000000000-00000","article-title":"Multiple peaking phenomena in pharmacokinetic disposition","volume":"49","author":"Davies","year":"2010","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bcp.2020.114314_b0270","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1172\/JCI107100","article-title":"Effect of cholestyramine on bile acid metabolism in normal man","volume":"51","author":"Garbutt","year":"1972","journal-title":"J. Clin. Invest."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220305505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220305505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:21:28Z","timestamp":1757769688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295220305505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":54,"alternative-id":["S0006295220305505"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114314","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics of CamSA, a potential prophylactic compound against Clostridioides difficile infections","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114314","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114314"}}